Clinical Trial Update: Colon Neoadjuvant FOLFOXIRI Study [Phase 2]

View source ↗

Summary

This update describes a Phase 2 trial evaluating neoadjuvant FOLFOXIRI therapy for rectal cancer, sponsored by the Chinese University of Hong Kong, currently sh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid) (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Rectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING